Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)
M. Imbrechts, W. Kerstens, M. Rasulova, T. Vercruysse, W. Maes, L. Ampofo, K. Ven, J. Lammertyn, K. Vanhoorelbeke, N. Callewaert, J. Neyts, K. Dallmeier, P. Declerck, H. J. Thibaut, N. Geukens
The paper evaluates a panel of anti-SARS-CoV-2 monoclonal antibodies for neutralizing activity against SARS-CoV-2 delta and omicron variants, finding three mAbs retain activity, with mAb 3B8 showing potent neutralization against both.
bioRxiv · Dec 21, 2021 · PreprintImmunology